Please provide your email address to receive an email when new articles are posted on . Selexipag improved pulmonary vascular resistance and other hemodynamic variables among patients with chronic ...

Please provide your email address to receive an email when new articles are posted on . In the phase 2 ARROW trial, selonsertib for 24 weeks failed to significantly reduce pulmonary vascular ...

Thus, the pattern of the resolution of pulmonary vascular disease after mitral-valve surgery is not clear. Furthermore, the influence of cardiopulmonary bypass and the characteristics of the ...

An ongoing multicenter study in Japan will evaluate reductions in pulmonary vascular resistance 8 months after initiating the combination therapy in pulmonary arterial hypertension. An ongoing study ...

Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension. NEW ORLEANS — ...

In adults with Fontan circulation, a higher pulmonary vascular resistance index (PVRI) during exercise and failure to reduce the PVRI were associated with a greater risk for death or heart ...

A major difficulty in the interpretation of these findings arises from the fact that closed commissurotomy often results in incomplete relief of obstruction, and it is difficult to determine whether ...

Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention. A new paper has highlighted the significant impact of type 2 ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.